Your browser doesn't support javascript.
loading
Comparison of the O-RADS and ADNEX models regarding malignancy rate and validity in evaluating adnexal lesions.
Chen, Guan-Yeu; Hsu, Teh-Fu; Chan, I-San; Liu, Chia-Hao; Chao, Wei-Ting; Shih, Ying-Chu; Jiang, Ling-Yu; Chang, Yen-Hou; Wang, Peng-Hui; Chen, Yi-Jen.
Afiliação
  • Chen GY; Department of Obstetrics and Gynecology, Taipei Veterans General Hospital, Taipei, Taiwan.
  • Hsu TF; Department of Obstetrics and Gynecology, National Yang Ming Chiao Tung University, Taipei, Taiwan.
  • Chan IS; Department of Emergency Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
  • Liu CH; College of Nursing, National Yang Ming Chiao Tung University, Taipei, Taiwan.
  • Chao WT; School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
  • Shih YC; Department of Obstetrics and Gynecology, Taipei Veterans General Hospital, Taipei, Taiwan.
  • Jiang LY; Department of Obstetrics and Gynecology, National Yang Ming Chiao Tung University, Taipei, Taiwan.
  • Chang YH; Department of Obstetrics and Gynecology, Taipei Veterans General Hospital, Taipei, Taiwan.
  • Wang PH; Department of Obstetrics and Gynecology, National Yang Ming Chiao Tung University, Taipei, Taiwan.
  • Chen YJ; School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Eur Radiol ; 32(11): 7854-7864, 2022 Nov.
Article em En | MEDLINE | ID: mdl-35583711
ABSTRACT

OBJECTIVE:

This study aimed to compare the ability of the O-RADS and ADNEX models to classify benign or malignant adnexal lesions.

METHODS:

This retrospective single-center study included women who underwent surgery for adnexal lesions. Two gynecologists independently categorized the adnexal lesions according to the O-RADS and ADNEX models. Four additional readers were included to validate the new quick-access O-RADS flowchart.

RESULTS:

Among the 322 patients included in this study, 264 (82.0%) had a benign diagnosis, and 58 (18.0%) had a malignant diagnosis. The malignant rates of O-RADS 2, O-RADS 3, O-RADS 4, and O-RADS 5 were 0%, 3.0%, 37.7%, and 78.9%, respectively. The AUC of the O-RADS in the 322 patients was 0.93. On comparing the O-RADS and ADNEX models in the remaining 281 patients, the AUCs of the O-RADS, ADNEX model with CA125, and ADNEX model without CA125 were 0.92, 0.95, and 0.94, respectively. When setting a uniform cutoff of ≥ 10% (≥ O-RADS 4) to predict malignancy, the O-RADS had higher sensitivity than the ADNEX model (96.6% vs. 91.4%), and relatively similar specificity. In addition, the readers with the quick-access flowchart spent less time categorizing O-RADS than the readers with only the original O-RADS table (mean analysis time 99 min 15 s vs. 111 min 55 s).

CONCLUSIONS:

The O-RADS classification of the adnexal lesions as benign or malignant was comparable to that of the ADNEX model and had higher sensitivity at the 10% cutoff value. A quick-access O-RADS flowchart was helpful in O-RADS categorization and might shorten the analysis time. KEY POINTS • Both O-RADS and ADNEX models had good diagnostic performance in distinguishing adnexal malignancy, and O-RADS had higher sensitivity than ADNEX model in uniform 10% cutoff to predict malignancy. • Quick-access O-RADS flowchart was developed to help review O-RADS classification and might help reduce the analysis time.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Doenças dos Anexos Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Doenças dos Anexos Idioma: En Ano de publicação: 2022 Tipo de documento: Article